News PageViaLase ViaLase Founder and CEO Tibor Juhasz, PhD, Receives 2022 Golden Goose Award ViaLase, Inc., announced that the company’s founder and CEO, Tibor Juhasz, Ph.D., was among five…Arboretum_JDOctober 11, 2022
Koya MedicalNews Page Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…Arboretum_JDOctober 4, 2022
DelphinusHome PageNews Page Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening Delphinus Medical Technologies, Inc. today announced the closing of a $30 million Series D financing to…Arboretum_JDSeptember 30, 2022
Francis MedicalNews Page Francis Medical Included as One of Ten Medical Device Startups You Need To Know Francis Medical has developed the Vanquish System, a minimally invasive transurethral prostate ablation device that…Arboretum_JDSeptember 27, 2022
DelphinusNews Page Karmanos Cancer Institute first to receive innovative, FDA-approved SoftVue™ Breast Imaging System The Barbara Ann Karmanos Cancer Institute, the world-renowned, Detroit-based National Cancer Institute-Designated Comprehensive Cancer Center, is the…Arboretum_JDSeptember 27, 2022
Home PageNavv SystemsNews Page Navv Systems Closes Series A Financing to Help Healthcare “Do More With Less” Navv Systems, a Southeastern Michigan-based healthcare technology company focused on healthcare personnel and equipment location…Arboretum_JDSeptember 15, 2022
Hicuity HealthNews Page MUSC Health Expands Telemedicine Partnership with Hicuity Health Hicuity Health, the nation's leading provider of high-acuity telemedicine services, announced the launch of tele-ICU…Arboretum_JDAugust 18, 2022
News PageStrata Oncology Strata Oncology Expands Strata PATH Trial to Eight Sarah Cannon Research Institute Sites Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today…Arboretum_JDAugust 16, 2022
EQRxNews Page EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate Progress EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…Arboretum_JDAugust 11, 2022
Home PageNews PagePear Therapeutics Pear Therapeutics to Be Added to Russell US Index Series Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription…Arboretum_JDAugust 3, 2022